Cargando…
Unresolved questions in selection of therapies for treatment-naïve chronic lymphocytic leukemia
BACKGROUND: The treatment landscape for chronic lymphocytic leukemia (CLL) continues to undergo considerable evolution. Optimal selection of initial therapy from multiple effective options provides a major challenge for clinicians, who need to consider both disease and patient factors in conjunction...
Autores principales: | Bennett, Rory, Anderson, Mary Ann, Seymour, John F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10329329/ https://www.ncbi.nlm.nih.gov/pubmed/37422670 http://dx.doi.org/10.1186/s13045-023-01469-7 |
Ejemplares similares
-
Promises and pitfalls of targeted agents in chronic lymphocytic leukemia
por: Lew, Thomas E., et al.
Publicado: (2020) -
Unresolved questions about the treatment of COVID-19 with corticosteroids()
por: Corral-Gudino, Luis, et al.
Publicado: (2021) -
Unresolved questions in the zoonotic transmission of MERS
por: Peiris, Malik, et al.
Publicado: (2022) -
Open questions: some unresolved issues in biodiversity
por: Magurran, Anne E
Publicado: (2013) -
Direct or indirect endothelial damage? An unresolved question
por: Basta, Giuseppina
Publicado: (2021)